FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 327:1613-1617 December 3, 1992 Number 23 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

BACKGROUND. Acute graft-versus-host disease (GVHD) is a serious complication of allogeneic bone marrow transplantation from an HLA-identical sibling. There is no practical test before transplantation that gives sufficient information to predict the degree of allogeneic reactivity between HLA-identical siblings. METHODS. We determined the frequency with which host-specific interleukin-2-secreting donor T-cell precursors occurred in 16 consecutive pairs of HLA-identical siblings before they underwent marrow grafting. The results were correlated with the development of acute GVHD after transplantation. RESULTS. High frequencies of host-specific T-cell precursors (> or = 1 per 100,000) were detectable before transplantation in eight donors whose siblings later had severe (grade II or III) acute GVHD. Among the donors to eight patients with mild (grade 0 or 1) acute GVHD, low frequencies (< 1 per 100,000) were found. CONCLUSIONS. Analysis of the frequency of such cells before transplantation may be a useful predictor of severe acute GVHD in allogeneic bone marrow transplantation between HLA-identical siblings. It is possible that the patients at risk for serious acute GVHD after marrow grafting may benefit from some alternative form of immunosuppressive therapy.

Source Information

Department of Internal Medicine III, University Hospital, Ulm, Germany.

This article has been cited by other articles:

• Hartwig, U. F., Robbers, M., Wickenhauser, C., Huber, C. (2002). Murine acute graft-versus-host disease can be prevented by depletion of alloreactive T lymphocytes using activation-induced cell death. Blood 99: 3041-3049 [Abstract] [Full Text]  
• Sehn, L. H., Alyea, E. P., Weller, E., Canning, C., Lee, S., Ritz, J., Antin, J. H., Soiffer, R. J. (1999). Comparative Outcomes of T-Cell–Depleted and Non–T-Cell–Depleted Allogeneic Bone Marrow Transplantation for Chronic Myelogenous Leukemia: Impact of Donor Lymphocyte Infusion. JCO 17: 561-561 [Abstract] [Full Text]  
• Middleton, P. G., Taylor, P. R.A., Jackson, G., Proctor, S. J., Dickinson, A. M. (1998). Cytokine Gene Polymorphisms Associating With Severe Acute Graft-Versus-Host Disease in HLA-Identical Sibling Transplants. Blood 92: 3943-3948 [Abstract] [Full Text]  
• Chalmers, I.M.H., Janossy, G., Contreras, M., Navarrete, C. (1998). Intracellular Cytokine Profile of Cord and Adult Blood Lymphocytes. Blood 92: 11-18 [Abstract] [Full Text]  
• Aractingi, S., Chosidow, O. (1998). Cutaneous Graft-versus-Host Disease. Arch Dermatol 134: 602-612 [Abstract] [Full Text]  
• Ferrara, J., Cooke, K., Pan, L, Krenger, W (1996). The immunopathophysiology of acute graft-versus-host-disease. Stem Cells 14: 473-489 [Abstract]  
• Quaglini, S., Bellazzi, R., Locatelli, F., Stefanelli, M., Salvaneschi, C. (1994). An Influence Diagram for Assessing GVHD Prophylaxis after Bone Marrow Transplantation in Children. Med Decis Making 14: 223-235 [Abstract]  
• Johnsen, H. E., Theobald, M. (1993). Predictors of Acute Graft-versus-Host Disease in Bone Marrow Transplantation between HLA-Identical Siblings. NEJM 328: 1497-1498 [Full Text]